UA93893C2 - Fsh mutants - Google Patents

Fsh mutants

Info

Publication number
UA93893C2
UA93893C2 UAA200808445A UAA200808445A UA93893C2 UA 93893 C2 UA93893 C2 UA 93893C2 UA A200808445 A UAA200808445 A UA A200808445A UA A200808445 A UAA200808445 A UA A200808445A UA 93893 C2 UA93893 C2 UA 93893C2
Authority
UA
Ukraine
Prior art keywords
fsh mutants
fsh
mutants
lives
human patients
Prior art date
Application number
UAA200808445A
Other languages
English (en)
Ukrainian (uk)
Inventor
Марко Мьюда
Сюлянь Дзянь
Шон Д. МакКенна
Original Assignee
Лаборатуар Cepoho C.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лаборатуар Cepoho C.A. filed Critical Лаборатуар Cepoho C.A.
Publication of UA93893C2 publication Critical patent/UA93893C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Изобретение относится к FSH-мутантам с повышенным уровнем гликозилирования и продолжительным периодом полувывода, а также к применению FSH-мутантов для индуцирования фоликулогенеза у больных людей.
UAA200808445A 2005-12-22 2006-12-21 Fsh mutants UA93893C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75363705P 2005-12-22 2005-12-22

Publications (1)

Publication Number Publication Date
UA93893C2 true UA93893C2 (en) 2011-03-25

Family

ID=38875495

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200808445A UA93893C2 (en) 2005-12-22 2006-12-21 Fsh mutants

Country Status (19)

Country Link
US (1) US7740862B2 (ru)
EP (1) EP1976872B1 (ru)
JP (1) JP5249044B2 (ru)
KR (1) KR20080087854A (ru)
CN (1) CN101341169B (ru)
AR (1) AR058615A1 (ru)
AU (1) AU2006346358B2 (ru)
BR (1) BRPI0620223A2 (ru)
CA (1) CA2630857A1 (ru)
EA (1) EA013975B1 (ru)
EC (1) ECSP088646A (ru)
ES (1) ES2543198T3 (ru)
IL (1) IL192096A (ru)
MX (1) MX2008008322A (ru)
MY (1) MY145839A (ru)
NZ (1) NZ568475A (ru)
UA (1) UA93893C2 (ru)
WO (1) WO2008010840A2 (ru)
ZA (1) ZA200804677B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103509121B (zh) 2012-11-22 2015-01-28 苏州康宁杰瑞生物科技有限公司 一种fsh融合蛋白及其制备方法和用途
KR101947340B1 (ko) * 2017-05-05 2019-02-12 주식회사 유비프로틴 FSHα 반감기를 증가시키는 방법
KR101947341B1 (ko) * 2017-05-05 2019-02-12 주식회사 유비프로틴 FSHβ 반감기를 증가시키는 방법
CN114213523B (zh) * 2021-11-15 2024-07-09 广州源博医药科技有限公司 一种用于重组蛋白的高糖基化修饰序列及其重组猪促卵泡激素和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2082424C (en) * 1990-05-08 2003-09-23 Robert K. Campbell Analogs of glycoprotein hormones having altered immunological characteristics, efficacy and/or receptor specificity
GB9403600D0 (en) * 1994-02-24 1994-04-13 Univ Glasgow Three dimensional hormone structure
WO2001058493A1 (en) 2000-02-11 2001-08-16 Maxygen Aps Conjugates of follicle stimulating hormones
AU2002368265B2 (en) * 2001-10-22 2007-06-07 Merck Serono Sa Mutant glycoproteins
UA88879C2 (en) 2003-09-02 2009-12-10 Эплайд Рисерч Системз Эрс Холдинг Н.В. Fsh glycosylation mutant
RU2006136919A (ru) * 2004-03-19 2008-04-27 Трофоджен, Инк. (Us) Суперагонисты фолликулостимулирующего гормона
ZA200805194B (en) * 2006-01-17 2009-10-28 Serono Lab Novel FSH glycosylation variant D3N

Also Published As

Publication number Publication date
CN101341169B (zh) 2012-09-05
AU2006346358B2 (en) 2012-01-19
BRPI0620223A2 (pt) 2011-11-01
WO2008010840A2 (en) 2008-01-24
JP5249044B2 (ja) 2013-07-31
US7740862B2 (en) 2010-06-22
ECSP088646A (es) 2008-08-29
EA200870108A1 (ru) 2009-12-30
ES2543198T3 (es) 2015-08-17
IL192096A0 (en) 2008-12-29
AR058615A1 (es) 2008-02-13
JP2009521222A (ja) 2009-06-04
EP1976872A2 (en) 2008-10-08
CA2630857A1 (en) 2008-01-24
NZ568475A (en) 2010-10-29
AU2006346358A1 (en) 2008-01-24
CN101341169A (zh) 2009-01-07
MY145839A (en) 2012-04-30
ZA200804677B (en) 2009-10-28
WO2008010840A3 (en) 2008-03-20
IL192096A (en) 2012-02-29
AU2006346358A2 (en) 2008-07-31
KR20080087854A (ko) 2008-10-01
MX2008008322A (es) 2008-10-01
US20090018070A1 (en) 2009-01-15
EP1976872B1 (en) 2015-06-17
EA013975B1 (ru) 2010-08-30

Similar Documents

Publication Publication Date Title
TW200612918A (en) Lonidamine analogs
CA101100S (en) Pillow
WO2005041719A3 (en) Pixelated support structures and elements
CA105195S (en) Bottle
RS89204A (en) Use of osteoprotegerin for the treatment and/or prevention of fibrotic disease
HK1101315A1 (en) Fsh glycosylation mutant fsh
MX2008008322A (es) Mutantes de fsh.
WO2007084441A3 (en) Novel fsh glycosylation variant d3n
AU301348S (en) Bottle with emphasized grip
CA115335S (en) Massage chair
CA115336S (en) Massage chair
CA104272S (en) Video monitor
CA115340S (en) Massage chair
CA115333S (en) Massage chair
WO2004050679A3 (en) Mutant glycoproteins
USD562460S1 (en) Orthopedic bench
CA115337S (en) Massage chair
MXPA04000418A (es) Tratamiento de dolor cronico con 3-heterocicloxi- y -cicloalquiloxi-3-fenilpropanaminas.
AU2003257624A1 (en) Medical instrument to be implanted in the body
EP1955334A4 (en) SHIELD ANTIRADIATION
AU2003209489A1 (en) Medical use of captopril for the treatment and prophylaxis of cancer
Perrings Human Well-Being and the Natural Environment
CA104435S (en) High-chair
AU306443S (en) Chair body
AU306442S (en) Chair body